

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 6.60082706 |
| 2 | positive regulation of synapse maturation (GO:0090129) | 5.72999965 |
| 3 | glutamate secretion (GO:0014047) | 5.72993270 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.64567646 |
| 5 | DNA deamination (GO:0045006) | 5.55915710 |
| 6 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.18648183 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.12817666 |
| 8 | ribosomal small subunit assembly (GO:0000028) | 5.06664717 |
| 9 | synaptic vesicle maturation (GO:0016188) | 4.93920678 |
| 10 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.89146176 |
| 11 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.71013896 |
| 12 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.70270819 |
| 13 | platelet dense granule organization (GO:0060155) | 4.59442515 |
| 14 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.59058822 |
| 15 | neurotransmitter secretion (GO:0007269) | 4.57001627 |
| 16 | viral transcription (GO:0019083) | 4.56894324 |
| 17 | DNA strand elongation (GO:0022616) | 4.49461650 |
| 18 | gonadal mesoderm development (GO:0007506) | 4.44492697 |
| 19 | cellular potassium ion homeostasis (GO:0030007) | 4.44079327 |
| 20 | DNA unwinding involved in DNA replication (GO:0006268) | 4.43096458 |
| 21 | translational termination (GO:0006415) | 4.33702772 |
| 22 | sodium ion export (GO:0071436) | 4.31142488 |
| 23 | mature B cell differentiation involved in immune response (GO:0002313) | 4.29731617 |
| 24 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.29055394 |
| 25 | positive regulation of B cell differentiation (GO:0045579) | 4.21445285 |
| 26 | DNA replication initiation (GO:0006270) | 4.20953404 |
| 27 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.20950343 |
| 28 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.17273064 |
| 29 | cerebellar granule cell differentiation (GO:0021707) | 4.16924989 |
| 30 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.11171536 |
| 31 | activation of MAPKKK activity (GO:0000185) | 4.09149853 |
| 32 | regulation of synapse maturation (GO:0090128) | 4.06474893 |
| 33 | regulation of B cell differentiation (GO:0045577) | 4.05752908 |
| 34 | regulation of ARF protein signal transduction (GO:0032012) | 4.01419477 |
| 35 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.92159931 |
| 36 | translational elongation (GO:0006414) | 3.91671092 |
| 37 | cytoplasmic sequestering of transcription factor (GO:0042994) | 3.75496660 |
| 38 | telomere maintenance via recombination (GO:0000722) | 3.73631732 |
| 39 | positive regulation of membrane potential (GO:0045838) | 3.71190805 |
| 40 | maturation of SSU-rRNA (GO:0030490) | 3.68660106 |
| 41 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.68291461 |
| 42 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.68291461 |
| 43 | immunoglobulin mediated immune response (GO:0016064) | 3.67262186 |
| 44 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.67074684 |
| 45 | pseudouridine synthesis (GO:0001522) | 3.61920803 |
| 46 | locomotory exploration behavior (GO:0035641) | 3.61351197 |
| 47 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.59121496 |
| 48 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.58911546 |
| 49 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.57303520 |
| 50 | endosome to pigment granule transport (GO:0043485) | 3.56886269 |
| 51 | endosome to melanosome transport (GO:0035646) | 3.56886269 |
| 52 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.54575647 |
| 53 | mature B cell differentiation (GO:0002335) | 3.53056039 |
| 54 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.52801039 |
| 55 | lymphoid progenitor cell differentiation (GO:0002320) | 3.51415832 |
| 56 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.51293794 |
| 57 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.50430143 |
| 58 | positive regulation of protein homooligomerization (GO:0032464) | 3.50194253 |
| 59 | B cell homeostasis (GO:0001782) | 3.48346615 |
| 60 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.47621724 |
| 61 | cotranslational protein targeting to membrane (GO:0006613) | 3.46231590 |
| 62 | ribosomal small subunit biogenesis (GO:0042274) | 3.42853806 |
| 63 | IMP metabolic process (GO:0046040) | 3.41261963 |
| 64 | viral life cycle (GO:0019058) | 3.40892265 |
| 65 | protein targeting to ER (GO:0045047) | 3.40461642 |
| 66 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.39454107 |
| 67 | regulation of interleukin-13 production (GO:0032656) | 3.39379091 |
| 68 | neuromuscular process controlling balance (GO:0050885) | 3.39240139 |
| 69 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.38674061 |
| 70 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.37415113 |
| 71 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.36018607 |
| 72 | mitotic G1/S transition checkpoint (GO:0044819) | 3.35555325 |
| 73 | positive regulation of protein oligomerization (GO:0032461) | 3.33420286 |
| 74 | response to interferon-beta (GO:0035456) | 3.33133541 |
| 75 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.32947280 |
| 76 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.30814319 |
| 77 | mitotic recombination (GO:0006312) | 3.30568535 |
| 78 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 3.30530531 |
| 79 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.29668409 |
| 80 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.28711245 |
| 81 | neurotransmitter transport (GO:0006836) | 3.28640698 |
| 82 | translational initiation (GO:0006413) | 3.28325306 |
| 83 | proline biosynthetic process (GO:0006561) | 3.24445975 |
| 84 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.23964184 |
| 85 | protein localization to endoplasmic reticulum (GO:0070972) | 3.23710205 |
| 86 | IMP biosynthetic process (GO:0006188) | 3.21240454 |
| 87 | telomere maintenance via telomere lengthening (GO:0010833) | 3.19527175 |
| 88 | G1 DNA damage checkpoint (GO:0044783) | 3.16870156 |
| 89 | regulation of regulatory T cell differentiation (GO:0045589) | 3.16207947 |
| 90 | cellular protein complex disassembly (GO:0043624) | 3.15599434 |
| 91 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.15213243 |
| 92 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.14681855 |
| 93 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.13072242 |
| 94 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.12651939 |
| 95 | nucleobase biosynthetic process (GO:0046112) | 3.12104347 |
| 96 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 3.11676969 |
| 97 | regulation of vesicle fusion (GO:0031338) | 3.10649606 |
| 98 | megakaryocyte development (GO:0035855) | 3.09994107 |
| 99 | regulation of T cell tolerance induction (GO:0002664) | 3.09114756 |
| 100 | protein complex disassembly (GO:0043241) | 3.04969887 |
| 101 | regulation of synaptic plasticity (GO:0048167) | 3.01877471 |
| 102 | thymic T cell selection (GO:0045061) | 3.01729291 |
| 103 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.00951131 |
| 104 | histone H4-K12 acetylation (GO:0043983) | 3.00927148 |
| 105 | regulation of synapse structural plasticity (GO:0051823) | 2.99334879 |
| 106 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 2.96528911 |
| 107 | L-amino acid import (GO:0043092) | 2.95968908 |
| 108 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.93333680 |
| 109 | B cell mediated immunity (GO:0019724) | 2.93022071 |
| 110 | negative regulation of B cell apoptotic process (GO:0002903) | 2.92218855 |
| 111 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.91081703 |
| 112 | mitochondrial calcium ion transport (GO:0006851) | 2.90984283 |
| 113 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.89701512 |
| 114 | Peyers patch development (GO:0048541) | 2.89701512 |
| 115 | cytoplasmic sequestering of protein (GO:0051220) | 2.88993045 |
| 116 | regulation of synaptic vesicle transport (GO:1902803) | 2.88705099 |
| 117 | negative regulation of mRNA processing (GO:0050686) | 2.87463400 |
| 118 | glycine transport (GO:0015816) | 2.87119212 |
| 119 | defense response to protozoan (GO:0042832) | 2.87083636 |
| 120 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.86373027 |
| 121 | layer formation in cerebral cortex (GO:0021819) | 2.85653643 |
| 122 | neuronal ion channel clustering (GO:0045161) | 2.85550281 |
| 123 | axon ensheathment in central nervous system (GO:0032291) | 2.84784218 |
| 124 | central nervous system myelination (GO:0022010) | 2.84784218 |
| 125 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.84552789 |
| 126 | glutamate receptor signaling pathway (GO:0007215) | 2.84456042 |
| 127 | regulation of neurotransmitter levels (GO:0001505) | 2.83002248 |
| 128 | T-helper 1 type immune response (GO:0042088) | 2.82425798 |
| 129 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.82292460 |
| 130 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.81858524 |
| 131 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.80817172 |
| 132 | myelin maintenance (GO:0043217) | 2.80700116 |
| 133 | signal complex assembly (GO:0007172) | 2.78886671 |
| 134 | peripheral nervous system neuron development (GO:0048935) | 2.77572615 |
| 135 | macromolecular complex disassembly (GO:0032984) | 2.77137117 |
| 136 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.75945650 |
| 137 | B cell activation involved in immune response (GO:0002312) | 2.75672497 |
| 138 | regulation of neurotransmitter secretion (GO:0046928) | 2.73342087 |
| 139 | synaptic transmission, glutamatergic (GO:0035249) | 2.73229023 |
| 140 | definitive hemopoiesis (GO:0060216) | 2.73024592 |
| 141 | mRNA catabolic process (GO:0006402) | 2.72441119 |
| 142 | neuronal action potential propagation (GO:0019227) | 2.71915133 |
| 143 | base-excision repair, AP site formation (GO:0006285) | 2.71216498 |
| 144 | positive regulation of tolerance induction (GO:0002645) | 2.70586567 |
| 145 | melanosome organization (GO:0032438) | 2.69712545 |
| 146 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.69047874 |
| 147 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.67609679 |
| 148 | RNA catabolic process (GO:0006401) | 2.67265678 |
| 149 | positive regulation of Rap GTPase activity (GO:0032854) | 2.66636212 |
| 150 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.65780266 |
| 151 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.65635854 |
| 152 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.65635854 |
| 153 | isotype switching (GO:0045190) | 2.65635854 |
| 154 | lymph node development (GO:0048535) | 2.65273721 |
| 155 | translesion synthesis (GO:0019985) | 2.65120229 |
| 156 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.64457116 |
| 157 | heterochromatin organization (GO:0070828) | 2.64383364 |
| 158 | positive thymic T cell selection (GO:0045059) | 2.64002266 |
| 159 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.63678982 |
| 160 | cell migration in hindbrain (GO:0021535) | 2.62902891 |
| 161 | mitochondrial DNA replication (GO:0006264) | 2.62677045 |
| 162 | potassium ion import (GO:0010107) | 2.62443247 |
| 163 | vocalization behavior (GO:0071625) | 2.62162130 |
| 164 | lymph vessel development (GO:0001945) | 2.60848053 |
| 165 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling | 2.60281658 |
| 166 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.60281658 |
| 167 | B cell receptor signaling pathway (GO:0050853) | 2.60237960 |
| 168 | mast cell activation (GO:0045576) | 2.60223699 |
| 169 | formation of translation preinitiation complex (GO:0001731) | 2.59403608 |
| 170 | exploration behavior (GO:0035640) | 2.58980247 |
| 171 | regulation of postsynaptic membrane potential (GO:0060078) | 2.58302104 |
| 172 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.58261945 |
| 173 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.58163735 |
| 174 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.58070543 |
| 175 | amino acid import (GO:0043090) | 2.57345305 |
| 176 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.57176715 |
| 177 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.56202879 |
| 178 | histone H3 deacetylation (GO:0070932) | 2.56025242 |
| 179 | potassium ion homeostasis (GO:0055075) | 2.55632671 |
| 180 | rRNA processing (GO:0006364) | 2.55396402 |
| 181 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.54839875 |
| 182 | purine nucleobase biosynthetic process (GO:0009113) | 2.54787108 |
| 183 | pigment granule organization (GO:0048753) | 2.54759516 |
| 184 | fucose catabolic process (GO:0019317) | 2.53842705 |
| 185 | L-fucose metabolic process (GO:0042354) | 2.53842705 |
| 186 | L-fucose catabolic process (GO:0042355) | 2.53842705 |
| 187 | respiratory chain complex IV assembly (GO:0008535) | 2.53560058 |
| 188 | positive regulation of defense response to virus by host (GO:0002230) | 2.53353140 |
| 189 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.53287038 |
| 190 | prepulse inhibition (GO:0060134) | 2.53058711 |
| 191 | secretory granule organization (GO:0033363) | 2.52540940 |
| 192 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.52369999 |
| 193 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.51288147 |
| 194 | sex determination (GO:0007530) | 2.51086000 |
| 195 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.51064501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.66840693 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.43866364 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.33622923 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.32364915 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.28407831 |
| 6 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.92534355 |
| 7 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.90859698 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.90390175 |
| 9 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.71391879 |
| 10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.60261178 |
| 11 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.50320911 |
| 12 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.46079091 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.38333885 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.32051174 |
| 15 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.30806914 |
| 16 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.26828950 |
| 17 | P68_20966046_ChIP-Seq_HELA_Human | 2.24093866 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.22177612 |
| 19 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.20910831 |
| 20 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.09626265 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.08401278 |
| 22 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.96783292 |
| 23 | KDM2B_26808549_Chip-Seq_K562_Human | 1.96170463 |
| 24 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95947841 |
| 25 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93070515 |
| 26 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.91259795 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.90672814 |
| 28 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.88771440 |
| 29 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.87834522 |
| 30 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.86302807 |
| 31 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.86118272 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.85157470 |
| 33 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.83041634 |
| 34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.82649677 |
| 35 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.81524344 |
| 36 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.80657318 |
| 37 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.80585106 |
| 38 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.78885016 |
| 39 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.78236283 |
| 40 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.77555025 |
| 41 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.77016687 |
| 42 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.74345814 |
| 43 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.73345400 |
| 44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.72465627 |
| 45 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.68465255 |
| 46 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.67486869 |
| 47 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.65871775 |
| 48 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.65378349 |
| 49 | MAF_26560356_Chip-Seq_TH1_Human | 1.65235295 |
| 50 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.64160313 |
| 51 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.64153593 |
| 52 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.62304733 |
| 53 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.61805493 |
| 54 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.61612392 |
| 55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.61481192 |
| 56 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.59636217 |
| 57 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.59386929 |
| 58 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.58411816 |
| 59 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.58297657 |
| 60 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.58106535 |
| 61 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.57757240 |
| 62 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.57011676 |
| 63 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.56868619 |
| 64 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.56717888 |
| 65 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.55667100 |
| 66 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.54396411 |
| 67 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.54384255 |
| 68 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.53226242 |
| 69 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.52818489 |
| 70 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.51891515 |
| 71 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.50477538 |
| 72 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.49943014 |
| 73 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49520616 |
| 74 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.49312701 |
| 75 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.47405355 |
| 76 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.46846033 |
| 77 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.46767505 |
| 78 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.45420046 |
| 79 | UTX_26944678_Chip-Seq_JUKART_Human | 1.45177269 |
| 80 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.42538099 |
| 81 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.42372958 |
| 82 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.42372958 |
| 83 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.41699481 |
| 84 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.41400834 |
| 85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40517206 |
| 86 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.40018416 |
| 87 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.38142534 |
| 88 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.37879717 |
| 89 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.37079697 |
| 90 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.36598657 |
| 91 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.36499524 |
| 92 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.36467180 |
| 93 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.35697301 |
| 94 | MYB_26560356_Chip-Seq_TH2_Human | 1.33940799 |
| 95 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.31875815 |
| 96 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.31708958 |
| 97 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.30911588 |
| 98 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.30249757 |
| 99 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.29904549 |
| 100 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.29696725 |
| 101 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.29552068 |
| 102 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.28061058 |
| 103 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.27150361 |
| 104 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.26615151 |
| 105 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.25538067 |
| 106 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.24779205 |
| 107 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.24412275 |
| 108 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.24043520 |
| 109 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.23828911 |
| 110 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.23569786 |
| 111 | MYB_26560356_Chip-Seq_TH1_Human | 1.23489916 |
| 112 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.22599936 |
| 113 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22581791 |
| 114 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.22257674 |
| 115 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.21756246 |
| 116 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.20210307 |
| 117 | MAF_26560356_Chip-Seq_TH2_Human | 1.19564265 |
| 118 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.18769288 |
| 119 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.18629658 |
| 120 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.18192671 |
| 121 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.18021288 |
| 122 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.17858441 |
| 123 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.17629025 |
| 124 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.17460470 |
| 125 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.16980723 |
| 126 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.16631674 |
| 127 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16135157 |
| 128 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.15397737 |
| 129 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.15003842 |
| 130 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.14966198 |
| 131 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.14256672 |
| 132 | SA1_27219007_Chip-Seq_Bcells_Human | 1.13455169 |
| 133 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13128040 |
| 134 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13121999 |
| 135 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.12902964 |
| 136 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.12322655 |
| 137 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.11478855 |
| 138 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10748613 |
| 139 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10574708 |
| 140 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.10277385 |
| 141 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.10091038 |
| 142 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.09602696 |
| 143 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.08840198 |
| 144 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.08803564 |
| 145 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08203087 |
| 146 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.08183045 |
| 147 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.07967866 |
| 148 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.07368617 |
| 149 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.07277558 |
| 150 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.07178114 |
| 151 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.06967305 |
| 152 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.05589947 |
| 153 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.05266579 |
| 154 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.05265306 |
| 155 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.05118872 |
| 156 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04571469 |
| 157 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.04527878 |
| 158 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.04484347 |
| 159 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.04335946 |
| 160 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.04080639 |
| 161 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.03342000 |
| 162 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03341429 |
| 163 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.03273706 |
| 164 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.03179957 |
| 165 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.02148705 |
| 166 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.00930302 |
| 167 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.00707326 |
| 168 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.99650648 |
| 169 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99376397 |
| 170 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98845606 |
| 171 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98525730 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.47300612 |
| 2 | MP0002396_abnormal_hematopoietic_system | 4.80065514 |
| 3 | MP0005423_abnormal_somatic_nervous | 4.65101734 |
| 4 | MP0005645_abnormal_hypothalamus_physiol | 3.94358111 |
| 5 | MP0000685_abnormal_immune_system | 3.55287746 |
| 6 | MP0005623_abnormal_meninges_morphology | 3.52408109 |
| 7 | MP0004147_increased_porphyrin_level | 3.38915036 |
| 8 | MP0001346_abnormal_lacrimal_gland | 3.26764090 |
| 9 | MP0001348_abnormal_lacrimal_gland | 3.14001340 |
| 10 | MP0003635_abnormal_synaptic_transmissio | 2.96604121 |
| 11 | MP0005174_abnormal_tail_pigmentation | 2.90940750 |
| 12 | MP0008995_early_reproductive_senescence | 2.82738329 |
| 13 | MP0010094_abnormal_chromosome_stability | 2.82325157 |
| 14 | MP0009046_muscle_twitch | 2.77548333 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.71802033 |
| 16 | MP0002064_seizures | 2.67494674 |
| 17 | MP0003866_abnormal_defecation | 2.67149591 |
| 18 | MP0003880_abnormal_central_pattern | 2.66824998 |
| 19 | MP0002249_abnormal_larynx_morphology | 2.57657171 |
| 20 | MP0008877_abnormal_DNA_methylation | 2.40739155 |
| 21 | MP0004808_abnormal_hematopoietic_stem | 2.32840604 |
| 22 | MP0005075_abnormal_melanosome_morpholog | 2.31401329 |
| 23 | MP0004270_analgesia | 2.30930390 |
| 24 | MP0009745_abnormal_behavioral_response | 2.30537608 |
| 25 | MP0004957_abnormal_blastocyst_morpholog | 2.29704942 |
| 26 | MP0000013_abnormal_adipose_tissue | 2.28295358 |
| 27 | MP0001502_abnormal_circadian_rhythm | 2.22178486 |
| 28 | MP0003693_abnormal_embryo_hatching | 2.21336296 |
| 29 | MP0001545_abnormal_hematopoietic_system | 2.19873001 |
| 30 | MP0005397_hematopoietic_system_phenotyp | 2.19873001 |
| 31 | MP0000678_abnormal_parathyroid_gland | 2.18940018 |
| 32 | MP0002398_abnormal_bone_marrow | 2.17999680 |
| 33 | MP0003077_abnormal_cell_cycle | 2.17486465 |
| 34 | MP0008058_abnormal_DNA_repair | 2.15606671 |
| 35 | MP0002063_abnormal_learning/memory/cond | 2.13809749 |
| 36 | MP0001800_abnormal_humoral_immune | 2.10352927 |
| 37 | MP0002272_abnormal_nervous_system | 2.09101074 |
| 38 | MP0000689_abnormal_spleen_morphology | 2.03426145 |
| 39 | MP0005671_abnormal_response_to | 2.00450874 |
| 40 | MP0008057_abnormal_DNA_replication | 1.97792729 |
| 41 | MP0008007_abnormal_cellular_replicative | 1.97705371 |
| 42 | MP0000490_abnormal_crypts_of | 1.94590622 |
| 43 | MP0009785_altered_susceptibility_to | 1.88519542 |
| 44 | MP0002877_abnormal_melanocyte_morpholog | 1.84598373 |
| 45 | MP0003763_abnormal_thymus_physiology | 1.82548493 |
| 46 | MP0002095_abnormal_skin_pigmentation | 1.82347791 |
| 47 | MP0003786_premature_aging | 1.81805048 |
| 48 | MP0002420_abnormal_adaptive_immunity | 1.80728063 |
| 49 | MP0000003_abnormal_adipose_tissue | 1.79336466 |
| 50 | MP0000716_abnormal_immune_system | 1.78665917 |
| 51 | MP0002452_abnormal_antigen_presenting | 1.77978610 |
| 52 | MP0002723_abnormal_immune_serum | 1.77307221 |
| 53 | MP0002722_abnormal_immune_system | 1.75486837 |
| 54 | MP0001819_abnormal_immune_cell | 1.73958966 |
| 55 | MP0005025_abnormal_response_to | 1.73278807 |
| 56 | MP0002734_abnormal_mechanical_nocicepti | 1.72829730 |
| 57 | MP0001188_hyperpigmentation | 1.72810561 |
| 58 | MP0001968_abnormal_touch/_nociception | 1.68881059 |
| 59 | MP0002429_abnormal_blood_cell | 1.68767401 |
| 60 | MP0002163_abnormal_gland_morphology | 1.61772964 |
| 61 | MP0002019_abnormal_tumor_incidence | 1.61713148 |
| 62 | MP0003879_abnormal_hair_cell | 1.60297549 |
| 63 | MP0001790_abnormal_immune_system | 1.58335177 |
| 64 | MP0005387_immune_system_phenotype | 1.58335177 |
| 65 | MP0002210_abnormal_sex_determination | 1.57159909 |
| 66 | MP0004885_abnormal_endolymph | 1.54755389 |
| 67 | MP0005499_abnormal_olfactory_system | 1.48736060 |
| 68 | MP0005394_taste/olfaction_phenotype | 1.48736060 |
| 69 | MP0005000_abnormal_immune_tolerance | 1.47471295 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 1.46350490 |
| 71 | MP0002572_abnormal_emotion/affect_behav | 1.45949972 |
| 72 | MP0004142_abnormal_muscle_tone | 1.45001091 |
| 73 | MP0001929_abnormal_gametogenesis | 1.45000620 |
| 74 | MP0001853_heart_inflammation | 1.40368455 |
| 75 | MP0001145_abnormal_male_reproductive | 1.38258891 |
| 76 | MP0005464_abnormal_platelet_physiology | 1.36390028 |
| 77 | MP0003111_abnormal_nucleus_morphology | 1.36270181 |
| 78 | MP0002148_abnormal_hypersensitivity_rea | 1.36077081 |
| 79 | MP0004811_abnormal_neuron_physiology | 1.31317209 |
| 80 | MP0004742_abnormal_vestibular_system | 1.31231670 |
| 81 | MP0003045_fibrosis | 1.30767940 |
| 82 | MP0000703_abnormal_thymus_morphology | 1.30384751 |
| 83 | MP0009278_abnormal_bone_marrow | 1.29212435 |
| 84 | MP0000015_abnormal_ear_pigmentation | 1.28423088 |
| 85 | MP0003878_abnormal_ear_physiology | 1.28042649 |
| 86 | MP0005377_hearing/vestibular/ear_phenot | 1.28042649 |
| 87 | MP0002735_abnormal_chemical_nociception | 1.22545362 |
| 88 | MP0009379_abnormal_foot_pigmentation | 1.22201395 |
| 89 | MP0002557_abnormal_social/conspecific_i | 1.21894681 |
| 90 | MP0000350_abnormal_cell_proliferation | 1.21861785 |
| 91 | MP0001270_distended_abdomen | 1.21738100 |
| 92 | MP0000313_abnormal_cell_death | 1.21237692 |
| 93 | MP0005375_adipose_tissue_phenotype | 1.19029324 |
| 94 | MP0008874_decreased_physiological_sensi | 1.18913244 |
| 95 | MP0001873_stomach_inflammation | 1.18157754 |
| 96 | MP0000653_abnormal_sex_gland | 1.17072962 |
| 97 | MP0002089_abnormal_postnatal_growth/wei | 1.15690893 |
| 98 | MP0005076_abnormal_cell_differentiation | 1.14472997 |
| 99 | MP0010155_abnormal_intestine_physiology | 1.12283408 |
| 100 | MP0001486_abnormal_startle_reflex | 1.09740963 |
| 101 | MP0000920_abnormal_myelination | 1.08733981 |
| 102 | MP0005670_abnormal_white_adipose | 1.07948637 |
| 103 | MP0002066_abnormal_motor_capabilities/c | 1.07733997 |
| 104 | MP0008569_lethality_at_weaning | 1.06357966 |
| 105 | MP0001730_embryonic_growth_arrest | 1.05968357 |
| 106 | MP0003646_muscle_fatigue | 1.05886518 |
| 107 | MP0002184_abnormal_innervation | 1.04604437 |
| 108 | MP0002733_abnormal_thermal_nociception | 1.00804072 |
| 109 | MP0002166_altered_tumor_susceptibility | 1.00756980 |
| 110 | MP0003329_amyloid_beta_deposits | 1.00389680 |
| 111 | MP0002405_respiratory_system_inflammati | 0.99225583 |
| 112 | MP0002234_abnormal_pharynx_morphology | 0.97290083 |
| 113 | MP0002653_abnormal_ependyma_morphology | 0.96585899 |
| 114 | MP0002067_abnormal_sensory_capabilities | 0.96316658 |
| 115 | MP0003303_peritoneal_inflammation | 0.95073917 |
| 116 | MP0002736_abnormal_nociception_after | 0.94848584 |
| 117 | MP0009333_abnormal_splenocyte_physiolog | 0.94026228 |
| 118 | MP0001970_abnormal_pain_threshold | 0.93516935 |
| 119 | MP0006292_abnormal_olfactory_placode | 0.92902497 |
| 120 | MP0001919_abnormal_reproductive_system | 0.92845528 |
| 121 | MP0002938_white_spotting | 0.91274177 |
| 122 | MP0002882_abnormal_neuron_morphology | 0.91269212 |
| 123 | MP0001440_abnormal_grooming_behavior | 0.90385158 |
| 124 | MP0001501_abnormal_sleep_pattern | 0.89306126 |
| 125 | MP0003315_abnormal_perineum_morphology | 0.85709919 |
| 126 | MP0003656_abnormal_erythrocyte_physiolo | 0.85572406 |
| 127 | MP0003698_abnormal_male_reproductive | 0.84666297 |
| 128 | MP0004145_abnormal_muscle_electrophysio | 0.83289829 |
| 129 | MP0008932_abnormal_embryonic_tissue | 0.81895412 |
| 130 | MP0002419_abnormal_innate_immunity | 0.80078187 |
| 131 | MP0003172_abnormal_lysosome_physiology | 0.77620534 |
| 132 | MP0002080_prenatal_lethality | 0.77507767 |
| 133 | MP0000955_abnormal_spinal_cord | 0.77417165 |
| 134 | MP0002152_abnormal_brain_morphology | 0.77371747 |
| 135 | MP0010678_abnormal_skin_adnexa | 0.76204884 |
| 136 | MP0004185_abnormal_adipocyte_glucose | 0.75506106 |
| 137 | MP0000681_abnormal_thyroid_gland | 0.75294892 |
| 138 | MP0004947_skin_inflammation | 0.74704943 |
| 139 | MP0000477_abnormal_intestine_morphology | 0.74220786 |
| 140 | MP0002006_tumorigenesis | 0.73929605 |
| 141 | MP0006036_abnormal_mitochondrial_physio | 0.73202412 |
| 142 | MP0003183_abnormal_peptide_metabolism | 0.73071083 |
| 143 | MP0002083_premature_death | 0.72973462 |
| 144 | MP0000613_abnormal_salivary_gland | 0.72871571 |
| 145 | MP0001845_abnormal_inflammatory_respons | 0.72791721 |
| 146 | MP0001697_abnormal_embryo_size | 0.72554027 |
| 147 | MP0003938_abnormal_ear_development | 0.71793704 |
| 148 | MP0001986_abnormal_taste_sensitivity | 0.71100439 |
| 149 | MP0000778_abnormal_nervous_system | 0.70995310 |
| 150 | MP0005666_abnormal_adipose_tissue | 0.70215926 |
| 151 | MP0000639_abnormal_adrenal_gland | 0.68661547 |
| 152 | MP0003633_abnormal_nervous_system | 0.66983718 |
| 153 | MP0003567_abnormal_fetal_cardiomyocyte | 0.66183001 |
| 154 | MP0002160_abnormal_reproductive_system | 0.65608461 |
| 155 | MP0009765_abnormal_xenobiotic_induced | 0.65284928 |
| 156 | MP0003634_abnormal_glial_cell | 0.64905273 |
| 157 | MP0003718_maternal_effect | 0.64758473 |
| 158 | MP0005310_abnormal_salivary_gland | 0.64676870 |
| 159 | MP0002873_normal_phenotype | 0.64006620 |
| 160 | MP0001881_abnormal_mammary_gland | 0.63572860 |
| 161 | MP0001963_abnormal_hearing_physiology | 0.63524578 |
| 162 | MP0002169_no_abnormal_phenotype | 0.63444211 |
| 163 | MP0002161_abnormal_fertility/fecundity | 0.63407068 |
| 164 | MP0000537_abnormal_urethra_morphology | 0.63372278 |
| 165 | MP0002075_abnormal_coat/hair_pigmentati | 0.63296354 |
| 166 | MP0003631_nervous_system_phenotype | 0.62292429 |
| 167 | MP0002177_abnormal_outer_ear | 0.61058083 |
| 168 | MP0004510_myositis | 0.59800734 |
| 169 | MP0005379_endocrine/exocrine_gland_phen | 0.59479720 |
| 170 | MP0010769_abnormal_survival | 0.57993709 |
| 171 | MP0004381_abnormal_hair_follicle | 0.57108513 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IgM deficiency (HP:0002850) | 5.34073520 |
| 2 | Myokymia (HP:0002411) | 5.31656122 |
| 3 | Aplastic anemia (HP:0001915) | 5.29392754 |
| 4 | Annular pancreas (HP:0001734) | 5.02741929 |
| 5 | Thrombocytosis (HP:0001894) | 5.00439947 |
| 6 | Gonadal dysgenesis (HP:0000133) | 4.68885439 |
| 7 | Chronic otitis media (HP:0000389) | 4.56422987 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.37889613 |
| 9 | Gastrointestinal stroma tumor (HP:0100723) | 3.57873496 |
| 10 | Cerebral hypomyelination (HP:0006808) | 3.54425198 |
| 11 | Recurrent bronchitis (HP:0002837) | 3.51156846 |
| 12 | Focal motor seizures (HP:0011153) | 3.49857167 |
| 13 | Colitis (HP:0002583) | 3.40939684 |
| 14 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.39786274 |
| 15 | Absence seizures (HP:0002121) | 3.34550517 |
| 16 | Interstitial pulmonary disease (HP:0006530) | 3.34129430 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 3.32417773 |
| 18 | Myositis (HP:0100614) | 3.29623079 |
| 19 | Recurrent sinusitis (HP:0011108) | 3.23877442 |
| 20 | Supranuclear gaze palsy (HP:0000605) | 3.17035217 |
| 21 | Abnormal number of erythroid precursors (HP:0012131) | 3.09048794 |
| 22 | Gastrointestinal inflammation (HP:0004386) | 3.03976356 |
| 23 | Cellulitis (HP:0100658) | 3.03729979 |
| 24 | Agammaglobulinemia (HP:0004432) | 2.98985168 |
| 25 | Male infertility (HP:0003251) | 2.98412460 |
| 26 | Generalized tonic-clonic seizures (HP:0002069) | 2.96747137 |
| 27 | Gonadotropin excess (HP:0000837) | 2.93536357 |
| 28 | Reticulocytopenia (HP:0001896) | 2.91303118 |
| 29 | CNS hypomyelination (HP:0003429) | 2.90928459 |
| 30 | Inflammation of the large intestine (HP:0002037) | 2.90874321 |
| 31 | Double outlet right ventricle (HP:0001719) | 2.90541334 |
| 32 | Congenital malformation of the right heart (HP:0011723) | 2.90541334 |
| 33 | Abnormality of T cell physiology (HP:0011840) | 2.90018382 |
| 34 | Obstructive sleep apnea (HP:0002870) | 2.88744904 |
| 35 | Erythema (HP:0010783) | 2.87320145 |
| 36 | Colon cancer (HP:0003003) | 2.87060523 |
| 37 | Broad face (HP:0000283) | 2.84126046 |
| 38 | Type I transferrin isoform profile (HP:0003642) | 2.81328053 |
| 39 | Epileptic encephalopathy (HP:0200134) | 2.80997800 |
| 40 | Impaired smooth pursuit (HP:0007772) | 2.80353467 |
| 41 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.78787521 |
| 42 | Visual hallucinations (HP:0002367) | 2.77802466 |
| 43 | Abnormality of the nasal mucosa (HP:0000433) | 2.77336064 |
| 44 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.76878363 |
| 45 | Dysmetric saccades (HP:0000641) | 2.71861504 |
| 46 | Acute lymphatic leukemia (HP:0006721) | 2.71689503 |
| 47 | Poikiloderma (HP:0001029) | 2.70728023 |
| 48 | Truncus arteriosus (HP:0001660) | 2.69826743 |
| 49 | Unilateral renal agenesis (HP:0000122) | 2.64657593 |
| 50 | Poor eye contact (HP:0000817) | 2.62814887 |
| 51 | Acute myeloid leukemia (HP:0004808) | 2.62688783 |
| 52 | Depression (HP:0000716) | 2.62378790 |
| 53 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.60105570 |
| 54 | Stridor (HP:0010307) | 2.59095928 |
| 55 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.56752819 |
| 56 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.56752819 |
| 57 | Action tremor (HP:0002345) | 2.56169499 |
| 58 | Athetosis (HP:0002305) | 2.54028881 |
| 59 | Ankle clonus (HP:0011448) | 2.53896953 |
| 60 | Septate vagina (HP:0001153) | 2.48053280 |
| 61 | Cholecystitis (HP:0001082) | 2.46564299 |
| 62 | Abnormal gallbladder physiology (HP:0012438) | 2.46564299 |
| 63 | Fatigue (HP:0012378) | 2.44390063 |
| 64 | Macrocytic anemia (HP:0001972) | 2.43539731 |
| 65 | Tetany (HP:0001281) | 2.43015146 |
| 66 | Focal seizures (HP:0007359) | 2.42785124 |
| 67 | Lymphoma (HP:0002665) | 2.42422410 |
| 68 | Febrile seizures (HP:0002373) | 2.42304015 |
| 69 | Pancytopenia (HP:0001876) | 2.41043204 |
| 70 | Dialeptic seizures (HP:0011146) | 2.39930166 |
| 71 | Emphysema (HP:0002097) | 2.39853907 |
| 72 | Pointed chin (HP:0000307) | 2.38512889 |
| 73 | IgG deficiency (HP:0004315) | 2.38035352 |
| 74 | Abnormality of binocular vision (HP:0011514) | 2.37554635 |
| 75 | Diplopia (HP:0000651) | 2.37554635 |
| 76 | Hypertensive crisis (HP:0100735) | 2.37071769 |
| 77 | Lower limb asymmetry (HP:0100559) | 2.35594644 |
| 78 | Truncal ataxia (HP:0002078) | 2.35481274 |
| 79 | Deep palmar crease (HP:0006191) | 2.34562742 |
| 80 | Postural instability (HP:0002172) | 2.34250801 |
| 81 | Lymphopenia (HP:0001888) | 2.33870322 |
| 82 | Transposition of the great arteries (HP:0001669) | 2.33738697 |
| 83 | Abnormal connection of the cardiac segments (HP:0011545) | 2.33738697 |
| 84 | Abnormal ventriculo-arterial connection (HP:0011563) | 2.33738697 |
| 85 | Akinesia (HP:0002304) | 2.30486604 |
| 86 | Neoplasm of the oral cavity (HP:0100649) | 2.29795180 |
| 87 | Overriding aorta (HP:0002623) | 2.29114673 |
| 88 | Ulnar bowing (HP:0003031) | 2.29029840 |
| 89 | Basal cell carcinoma (HP:0002671) | 2.28393692 |
| 90 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.27468896 |
| 91 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.26148708 |
| 92 | Abnormal sex determination (HP:0012244) | 2.23188601 |
| 93 | Sex reversal (HP:0012245) | 2.23188601 |
| 94 | Amaurosis fugax (HP:0100576) | 2.22075760 |
| 95 | Nasal polyposis (HP:0100582) | 2.20885040 |
| 96 | Hyperacusis (HP:0010780) | 2.20806801 |
| 97 | Broad distal phalanx of finger (HP:0009836) | 2.20624145 |
| 98 | Reduced antithrombin III activity (HP:0001976) | 2.19982466 |
| 99 | Hyperthyroidism (HP:0000836) | 2.19140121 |
| 100 | Oral leukoplakia (HP:0002745) | 2.18829690 |
| 101 | Albinism (HP:0001022) | 2.18512926 |
| 102 | Type II lissencephaly (HP:0007260) | 2.16659086 |
| 103 | Severe visual impairment (HP:0001141) | 2.15979417 |
| 104 | Abnormality of DNA repair (HP:0003254) | 2.15245641 |
| 105 | Pulmonary fibrosis (HP:0002206) | 2.13915559 |
| 106 | Entropion (HP:0000621) | 2.13527293 |
| 107 | IgA deficiency (HP:0002720) | 2.13107344 |
| 108 | Turricephaly (HP:0000262) | 2.12916263 |
| 109 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.11245047 |
| 110 | Abnormal protein glycosylation (HP:0012346) | 2.11245047 |
| 111 | Abnormal glycosylation (HP:0012345) | 2.11245047 |
| 112 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.11245047 |
| 113 | Hepatocellular necrosis (HP:0001404) | 2.11155697 |
| 114 | Mesangial abnormality (HP:0001966) | 2.10742407 |
| 115 | B lymphocytopenia (HP:0010976) | 2.10039155 |
| 116 | Abnormality of B cell number (HP:0010975) | 2.10039155 |
| 117 | Nonprogressive disorder (HP:0003680) | 2.08888607 |
| 118 | Progressive cerebellar ataxia (HP:0002073) | 2.08800154 |
| 119 | Secondary amenorrhea (HP:0000869) | 2.08280986 |
| 120 | Restrictive lung disease (HP:0002091) | 2.07432398 |
| 121 | Optic nerve coloboma (HP:0000588) | 2.06866210 |
| 122 | Ragged-red muscle fibers (HP:0003200) | 2.06384541 |
| 123 | Bronchitis (HP:0012387) | 2.04624192 |
| 124 | Abnormality of macrophages (HP:0004311) | 2.03849300 |
| 125 | Dysmetria (HP:0001310) | 2.03485456 |
| 126 | Abnormality of the columella (HP:0009929) | 2.02484997 |
| 127 | Intestinal fistula (HP:0100819) | 2.01548174 |
| 128 | Pallor (HP:0000980) | 2.01107793 |
| 129 | Impaired social interactions (HP:0000735) | 2.00929296 |
| 130 | Abnormal social behavior (HP:0012433) | 2.00929296 |
| 131 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.00282672 |
| 132 | Long palpebral fissure (HP:0000637) | 1.98704915 |
| 133 | Elfin facies (HP:0004428) | 1.98249117 |
| 134 | Male pseudohermaphroditism (HP:0000037) | 1.98086590 |
| 135 | Vasculitis (HP:0002633) | 1.98011649 |
| 136 | Progressive muscle weakness (HP:0003323) | 1.96760470 |
| 137 | Insomnia (HP:0100785) | 1.96521754 |
| 138 | Delusions (HP:0000746) | 1.95637328 |
| 139 | Selective tooth agenesis (HP:0001592) | 1.95372759 |
| 140 | Stereotypic behavior (HP:0000733) | 1.94358062 |
| 141 | Spastic gait (HP:0002064) | 1.94280775 |
| 142 | Broad alveolar ridges (HP:0000187) | 1.94017632 |
| 143 | Ocular albinism (HP:0001107) | 1.93434849 |
| 144 | Abnormality of male internal genitalia (HP:0000022) | 1.93419861 |
| 145 | Squamous cell carcinoma (HP:0002860) | 1.93378597 |
| 146 | Rectal fistula (HP:0100590) | 1.92832191 |
| 147 | Rectovaginal fistula (HP:0000143) | 1.92832191 |
| 148 | Cutaneous melanoma (HP:0012056) | 1.92075036 |
| 149 | Periauricular skin pits (HP:0100277) | 1.91340101 |
| 150 | Preauricular pit (HP:0004467) | 1.91340101 |
| 151 | Recurrent viral infections (HP:0004429) | 1.90812735 |
| 152 | Abnormality of saccadic eye movements (HP:0000570) | 1.90047094 |
| 153 | Recurrent otitis media (HP:0000403) | 1.89972031 |
| 154 | Meningitis (HP:0001287) | 1.88720835 |
| 155 | Atonic seizures (HP:0010819) | 1.88539482 |
| 156 | Postnatal microcephaly (HP:0005484) | 1.86813195 |
| 157 | Hypoproteinemia (HP:0003075) | 1.86249141 |
| 158 | Birth length less than 3rd percentile (HP:0003561) | 1.85305362 |
| 159 | Facial diplegia (HP:0001349) | 1.84495370 |
| 160 | Abnormality of the aortic arch (HP:0012303) | 1.84242495 |
| 161 | Abnormality of T cells (HP:0002843) | 1.84171221 |
| 162 | Myelodysplasia (HP:0002863) | 1.83860740 |
| 163 | Trigonocephaly (HP:0000243) | 1.83109853 |
| 164 | Increased purine levels (HP:0004368) | 1.82298259 |
| 165 | Hyperuricemia (HP:0002149) | 1.82298259 |
| 166 | Large eyes (HP:0001090) | 1.81908287 |
| 167 | Asplenia (HP:0001746) | 1.81723680 |
| 168 | Mediastinal lymphadenopathy (HP:0100721) | 1.81701764 |
| 169 | Medulloblastoma (HP:0002885) | 1.81404061 |
| 170 | Bradykinesia (HP:0002067) | 1.81335665 |
| 171 | Gout (HP:0001997) | 1.80604315 |
| 172 | Asymmetric growth (HP:0100555) | 1.79852577 |
| 173 | Polygenic inheritance (HP:0010982) | 1.79574739 |
| 174 | Neuronal loss in central nervous system (HP:0002529) | 1.79319057 |
| 175 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.79248718 |
| 176 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.79122957 |
| 177 | Abnormality of chromosome segregation (HP:0002916) | 1.78195101 |
| 178 | Microcytic anemia (HP:0001935) | 1.78072933 |
| 179 | Spastic tetraparesis (HP:0001285) | 1.76122476 |
| 180 | Hypercortisolism (HP:0001578) | 1.75279116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FLT3 | 4.65154914 |
| 2 | KIT | 4.55038759 |
| 3 | SMG1 | 4.07755338 |
| 4 | TNIK | 3.68442310 |
| 5 | TRIB3 | 3.60180605 |
| 6 | CSF1R | 3.55542545 |
| 7 | PRPF4B | 3.50348753 |
| 8 | EEF2K | 3.50122825 |
| 9 | MAP3K9 | 3.47646200 |
| 10 | WEE1 | 3.46687034 |
| 11 | CDK19 | 3.08406814 |
| 12 | MAP4K1 | 3.01897043 |
| 13 | NME2 | 2.88868906 |
| 14 | ARAF | 2.37194114 |
| 15 | ACVR1B | 2.34152298 |
| 16 | TGFBR1 | 2.31648228 |
| 17 | CDK12 | 2.25130314 |
| 18 | RIPK4 | 2.18414400 |
| 19 | WNK4 | 2.06395599 |
| 20 | CAMKK1 | 2.02716546 |
| 21 | MAPKAPK5 | 1.96515219 |
| 22 | STK39 | 1.96476406 |
| 23 | BTK | 1.94640820 |
| 24 | BUB1 | 1.85229719 |
| 25 | SCYL2 | 1.82885367 |
| 26 | NTRK2 | 1.63961856 |
| 27 | MATK | 1.63037381 |
| 28 | RPS6KB2 | 1.54432502 |
| 29 | WNK1 | 1.51032866 |
| 30 | NEK2 | 1.49817541 |
| 31 | DAPK2 | 1.47349337 |
| 32 | PKN2 | 1.44331702 |
| 33 | JAK3 | 1.44182797 |
| 34 | CDK7 | 1.43697423 |
| 35 | BCKDK | 1.43334599 |
| 36 | PAK6 | 1.41810733 |
| 37 | BRAF | 1.40958131 |
| 38 | SIK3 | 1.39513292 |
| 39 | PIM2 | 1.38312800 |
| 40 | ADRBK2 | 1.32499103 |
| 41 | EPHA4 | 1.28364417 |
| 42 | SIK2 | 1.27029870 |
| 43 | NTRK3 | 1.25948628 |
| 44 | CDK4 | 1.24949103 |
| 45 | TEC | 1.24619354 |
| 46 | MAP3K6 | 1.23606376 |
| 47 | RIPK1 | 1.19130973 |
| 48 | MAPKAPK3 | 1.18384390 |
| 49 | TGFBR2 | 1.16097953 |
| 50 | PRKCH | 1.15344268 |
| 51 | MAP3K10 | 1.14586003 |
| 52 | EPHB1 | 1.08768585 |
| 53 | PRKD3 | 1.08504392 |
| 54 | CDC7 | 1.06287153 |
| 55 | STK16 | 1.05759427 |
| 56 | CDK11A | 1.04305636 |
| 57 | PDPK1 | 1.03825951 |
| 58 | IRAK2 | 1.03563024 |
| 59 | SIK1 | 1.01665053 |
| 60 | RAF1 | 1.01650664 |
| 61 | SYK | 1.00566443 |
| 62 | NLK | 0.99413281 |
| 63 | MAP2K3 | 0.97640533 |
| 64 | FES | 0.97110262 |
| 65 | MAPK12 | 0.95235221 |
| 66 | MARK2 | 0.95105588 |
| 67 | IRAK4 | 0.92232668 |
| 68 | MUSK | 0.91485006 |
| 69 | MAP3K14 | 0.91033732 |
| 70 | PKN1 | 0.90159753 |
| 71 | CDK15 | 0.88441192 |
| 72 | PDK1 | 0.87961772 |
| 73 | ALK | 0.86000171 |
| 74 | BLK | 0.82376292 |
| 75 | CCNB1 | 0.81662974 |
| 76 | MARK1 | 0.80297095 |
| 77 | CAMKK2 | 0.79903201 |
| 78 | CDK18 | 0.79854399 |
| 79 | DAPK1 | 0.79382349 |
| 80 | TAOK2 | 0.78300582 |
| 81 | BRSK2 | 0.78112263 |
| 82 | TYRO3 | 0.77848329 |
| 83 | CDK8 | 0.76704270 |
| 84 | DAPK3 | 0.75690966 |
| 85 | MKNK1 | 0.75022110 |
| 86 | MAP3K1 | 0.73816931 |
| 87 | LRRK2 | 0.72947370 |
| 88 | DYRK3 | 0.72056315 |
| 89 | MELK | 0.71957779 |
| 90 | RPS6KA5 | 0.71853797 |
| 91 | CDC42BPA | 0.71568680 |
| 92 | CDK5 | 0.70094413 |
| 93 | CAMK1 | 0.70000579 |
| 94 | MAPK15 | 0.68488632 |
| 95 | MINK1 | 0.67472773 |
| 96 | CDK14 | 0.65167087 |
| 97 | IKBKE | 0.64343811 |
| 98 | CAMK2B | 0.64131103 |
| 99 | PAK4 | 0.63623189 |
| 100 | CSNK1G3 | 0.62315957 |
| 101 | LCK | 0.61860520 |
| 102 | ZAP70 | 0.59949480 |
| 103 | CLK1 | 0.58335841 |
| 104 | NME1 | 0.57612841 |
| 105 | PRKCI | 0.56768961 |
| 106 | MAP3K13 | 0.56081207 |
| 107 | IRAK3 | 0.55099400 |
| 108 | FGR | 0.54646413 |
| 109 | STK10 | 0.54509898 |
| 110 | TBK1 | 0.53991247 |
| 111 | SGK223 | 0.53361692 |
| 112 | SGK494 | 0.53361692 |
| 113 | PRKCQ | 0.52004649 |
| 114 | MOS | 0.51665148 |
| 115 | MAPK10 | 0.51618424 |
| 116 | LYN | 0.50344306 |
| 117 | MAPK11 | 0.49389693 |
| 118 | CSNK1A1L | 0.49010525 |
| 119 | MAP2K2 | 0.48736272 |
| 120 | CAMK4 | 0.48276793 |
| 121 | VRK2 | 0.47627262 |
| 122 | ATR | 0.47126286 |
| 123 | TNK2 | 0.46766399 |
| 124 | CDK2 | 0.46282376 |
| 125 | GRK5 | 0.46210591 |
| 126 | ERN1 | 0.45948554 |
| 127 | BRSK1 | 0.45873142 |
| 128 | PIM1 | 0.45815407 |
| 129 | VRK1 | 0.45411834 |
| 130 | PASK | 0.44817964 |
| 131 | STK11 | 0.44567006 |
| 132 | MAP3K11 | 0.43578553 |
| 133 | MAP3K7 | 0.43520957 |
| 134 | CHEK2 | 0.43394324 |
| 135 | MTOR | 0.43368059 |
| 136 | BRD4 | 0.41293302 |
| 137 | TAOK1 | 0.40202884 |
| 138 | PLK1 | 0.39171255 |
| 139 | MARK3 | 0.38985620 |
| 140 | RPS6KA4 | 0.38693438 |
| 141 | CDK9 | 0.37761842 |
| 142 | CHUK | 0.37597267 |
| 143 | KSR1 | 0.36736158 |
| 144 | CSNK1G1 | 0.36632206 |
| 145 | TYK2 | 0.36164684 |
| 146 | MAPK8 | 0.36149708 |
| 147 | HIPK2 | 0.35952700 |
| 148 | DYRK2 | 0.34930975 |
| 149 | AKT2 | 0.34926934 |
| 150 | GRK6 | 0.30524234 |
| 151 | ICK | 0.28041460 |
| 152 | RET | 0.27727944 |
| 153 | IKBKB | 0.27358264 |
| 154 | KSR2 | 0.26007762 |
| 155 | MAP3K8 | 0.25798574 |
| 156 | UHMK1 | 0.25080424 |
| 157 | TLK1 | 0.24848338 |
| 158 | ILK | 0.23842899 |
| 159 | STK4 | 0.23432177 |
| 160 | PAK1 | 0.23064168 |
| 161 | CHEK1 | 0.22753783 |
| 162 | AURKA | 0.22605327 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 5.85763882 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 4.22176630 |
| 3 | Base excision repair_Homo sapiens_hsa03410 | 3.75234756 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.65441404 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.89467585 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.89112519 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.88474514 |
| 8 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.76972217 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.61750984 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 2.56028894 |
| 11 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.53971511 |
| 12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.41374019 |
| 13 | Homologous recombination_Homo sapiens_hsa03440 | 2.40338270 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.38870681 |
| 15 | Spliceosome_Homo sapiens_hsa03040 | 2.31505943 |
| 16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.31104866 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.29793885 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.18250845 |
| 19 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.08057545 |
| 20 | Long-term potentiation_Homo sapiens_hsa04720 | 2.06330123 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.04948775 |
| 22 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.98010540 |
| 23 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.92534912 |
| 24 | Cell cycle_Homo sapiens_hsa04110 | 1.91074938 |
| 25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.82702757 |
| 26 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.82020621 |
| 27 | RNA degradation_Homo sapiens_hsa03018 | 1.59108929 |
| 28 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.58812268 |
| 29 | Asthma_Homo sapiens_hsa05310 | 1.57422778 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.57358490 |
| 31 | RNA transport_Homo sapiens_hsa03013 | 1.55377228 |
| 32 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.54791670 |
| 33 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.47452488 |
| 34 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.45423995 |
| 35 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.44520201 |
| 36 | Basal transcription factors_Homo sapiens_hsa03022 | 1.44214322 |
| 37 | Sulfur relay system_Homo sapiens_hsa04122 | 1.38744512 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.37436352 |
| 39 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.35022534 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.27714520 |
| 41 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.26273567 |
| 42 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.25288020 |
| 43 | Cocaine addiction_Homo sapiens_hsa05030 | 1.24564264 |
| 44 | Purine metabolism_Homo sapiens_hsa00230 | 1.23686006 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21837349 |
| 46 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.20638730 |
| 47 | Circadian entrainment_Homo sapiens_hsa04713 | 1.19437734 |
| 48 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.19240658 |
| 49 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.18913535 |
| 50 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.16588996 |
| 51 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.11950573 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.11357489 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 1.10418284 |
| 54 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.10318543 |
| 55 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.09721984 |
| 56 | Thyroid cancer_Homo sapiens_hsa05216 | 1.08406737 |
| 57 | GABAergic synapse_Homo sapiens_hsa04727 | 1.07816598 |
| 58 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.07547422 |
| 59 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.06792765 |
| 60 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.05684237 |
| 61 | Morphine addiction_Homo sapiens_hsa05032 | 1.05683910 |
| 62 | Proteasome_Homo sapiens_hsa03050 | 1.01777355 |
| 63 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.01735416 |
| 64 | Glioma_Homo sapiens_hsa05214 | 1.00185666 |
| 65 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.94240522 |
| 66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.93855186 |
| 67 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.92350708 |
| 68 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.92290512 |
| 69 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.92088020 |
| 70 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.90443771 |
| 71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.87558013 |
| 72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.87269367 |
| 73 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.87047705 |
| 74 | Insulin secretion_Homo sapiens_hsa04911 | 0.86388367 |
| 75 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.85927328 |
| 76 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.85005835 |
| 77 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.82657217 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80509497 |
| 79 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.80357123 |
| 80 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.79400790 |
| 81 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.79298510 |
| 82 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.76870194 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 0.76793125 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.76790653 |
| 85 | Leishmaniasis_Homo sapiens_hsa05140 | 0.76285647 |
| 86 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.76047038 |
| 87 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.75689474 |
| 88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.73463773 |
| 89 | Prion diseases_Homo sapiens_hsa05020 | 0.71633030 |
| 90 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.68109895 |
| 91 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.66580188 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66134236 |
| 93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65919640 |
| 94 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65406204 |
| 95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64797672 |
| 96 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63186254 |
| 97 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.63154764 |
| 98 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.63086659 |
| 99 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.62942978 |
| 100 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.62652004 |
| 101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61679631 |
| 102 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.61260678 |
| 103 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.61064699 |
| 104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60684838 |
| 105 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.59495076 |
| 106 | Melanogenesis_Homo sapiens_hsa04916 | 0.58714869 |
| 107 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.57810720 |
| 108 | HTLV-I infection_Homo sapiens_hsa05166 | 0.57696891 |
| 109 | Measles_Homo sapiens_hsa05162 | 0.56711675 |
| 110 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55784079 |
| 111 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.55457656 |
| 112 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54836343 |
| 113 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.54316831 |
| 114 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.54108926 |
| 115 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.51732529 |
| 116 | Apoptosis_Homo sapiens_hsa04210 | 0.51494317 |
| 117 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.51463343 |
| 118 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51293644 |
| 119 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50721622 |
| 120 | Salmonella infection_Homo sapiens_hsa05132 | 0.50245859 |
| 121 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.49593473 |
| 122 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.49196691 |
| 123 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48593337 |
| 124 | Endocytosis_Homo sapiens_hsa04144 | 0.47876490 |
| 125 | Hepatitis C_Homo sapiens_hsa05160 | 0.47620880 |
| 126 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.47298412 |
| 127 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.45834818 |
| 128 | Salivary secretion_Homo sapiens_hsa04970 | 0.45274189 |
| 129 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.45132693 |
| 130 | Hepatitis B_Homo sapiens_hsa05161 | 0.44798943 |
| 131 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44436465 |
| 132 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.43901985 |
| 133 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43011391 |
| 134 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.41867397 |
| 135 | Alcoholism_Homo sapiens_hsa05034 | 0.41847422 |
| 136 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41735596 |
| 137 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.41502449 |
| 138 | Colorectal cancer_Homo sapiens_hsa05210 | 0.41312312 |
| 139 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39136685 |
| 140 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.36262310 |
| 141 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.35297739 |
| 142 | Influenza A_Homo sapiens_hsa05164 | 0.34463745 |
| 143 | Long-term depression_Homo sapiens_hsa04730 | 0.31621063 |
| 144 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.30789220 |
| 145 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.30702400 |
| 146 | Pathways in cancer_Homo sapiens_hsa05200 | 0.27808614 |
| 147 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.27060859 |
| 148 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.26145717 |
| 149 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.24540425 |
| 150 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.22869236 |
| 151 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.22142629 |
| 152 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.21712445 |
| 153 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.18987115 |
| 154 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.18337044 |
| 155 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.17991408 |
| 156 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.16506400 |
| 157 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.15966048 |
| 158 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.15816020 |
| 159 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.15197804 |
| 160 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.15085374 |

